Apyx Medical says Renuvion study shows increased elastin and reduced inflammation at 180 days

Apyx Medical disclosed results from a prospective clinical study of its Renuvion device, now published in a peer-reviewed journal, reporting biopsy findings of increased elastin, reduced inflammation and favorable tissue remodeling at 180 days, with no abnormal healing safety signals.